国: アイルランド
言語: 英語
ソース: HPRA (Health Products Regulatory Authority)
Darunavir
Accord Healthcare Ireland Ltd.
J05AE; J05AE10
Darunavir
600 milligram(s)
Film-coated tablet
Protease inhibitors; darunavir
2019-08-30
1 PACKAGE LEAFLET: INFORMATION FOR THE USER [INVENTED NAME] 75 MG FILM-COATED TABLETS [INVENTED NAME] 150 MG FILM-COATED TABLETS [INVENTED NAME] 300 MG FILM-COATED TABLETS [INVENTED NAME] 600 MG FILM-COATED TABLETS darunavir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [Invented name] is and what it is used for 2. What you need to know before you take [Invented name] 3. How to take [Invented name] 4. Possible side effects 5. How to store [Invented name] 6. Contents of the pack and other information 1. WHAT [INVENTED NAME] IS AND WHAT IT IS USED FOR WHAT IS [INVENTED NAME]? [Invented name] contains the active substance darunavir. [Invented name] is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. This medicine works by reducing the amount of HIV in your body. This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection. WHAT IT IS USED FOR? [Invented name] is used to treat adults and children of 3 years of age and above, and at least 15 kilogram body weight who are infected by HIV and who have already used other antiretroviral medicines. [Invented name] must be taken in combination with a low dose of ritonavir and other anti-HIV medicines. Your doctor will discuss with you which combination of medicines is best for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE [INVENTED NAME] DO NOT TAKE [INVENTED NAME] - if you are ALLERGIC 完全なドキュメントを読む
Health║Products║Regulatory║Authority 22║November║2019 CRN008YH4 Page║1║of║32 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Darunavir║Accord║600║mg║film-coated║tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Darunavir Accord 600 mg film-coated tablets Each║film-coated║tablet║contains║600║mg║of║darunavir║(as ║propylene║glycolate). _Excipients with known effect_ Each║film-coated║tablet║contains║2.88║mg║of║Sunset║Yellow║FCF║Aluminum║Lake║(E110). Each║film-coated║tablet║contains║113.90║mg║of║lactose║monohydrate. Each║film-coated║tablet║contains║83.33║mg║of║propylene║glycol║(E1520). For║the║full║list║of║excipients,║see║section║6.1. 3 PHARMACEUTICAL FORM Film-coated║tablet. Orange║oval║shaped║tablet,║debossed║with║"600"║on║one║side║with║dimensions:║Length:║20.2±0.2║mm,║Width:║10.2║±║0.2║mm║and Thickness:║6.8±0.4mm.║ 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Darunavir║Accord║co-administered║with║low║dose║ritonavir║is║indicated║in║combination║with║other║antiretroviral║medicinal║ products║for║the║treatment║of║patients║with║human║immunodeficiency║virus║(HIV-1)║infection ║(see║section║4.2). Darunavir║Accord║600║mg║tablets║may║be║used║to║provide║suitable║dose║regimens║(see║section║4.2): For║the║treatment║of║HIV-1║infection║in║antiretroviral║treatment║(ART)-experienced║adult║patients,║including║those║ that║have║been║highly║pre-treated. For║the║treatment║of║HIV-1║infection║in║paediatric║patients║from║the║age║of║3║years║and║at║least║15║kg║body║weight. In║deciding║to║initiate║treatment║with║Darunavir║Accord║co-administered║with║low║dose║ritonavir,║careful║consideration║should║ be║given║to║the║treatment║history║of║th 完全なドキュメントを読む